CV Sciences (CVSI) Change in Cash (2011 - 2026)
CV Sciences (CVSI) reported Change in Cash of $31000.0 for Q1 2026, down 91.34% on a YoY basis from $358000.0 in Q1 2025, and up 130.1% sequentially from -$103000.0 in Q4 2025.
CV Sciences (CVSI) Change in Cash (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Change in Cash data on file, last reported at $31000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 91.34% year-over-year to $31000.0; the trailing twelve-month figure through Mar 2026 stood at -$503000.0 (down 435.33% YoY), and the FY2025 full-year result was -$176000.0, up 79.61% from the prior year.
- Change in Cash climbed to $31000.0 in Q1 2026, from -$103000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $1.1 million in Q1 2022 to a low of -$1.3 million in Q2 2022.
- A 5-year average of -$62705.9 and a median of -$47000.0 in 2023 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 1168.09% in 2024, while the deepest fall reached 735.92% in 2024.
- Tracing CVSI's Change in Cash over 5 years: stood at -$528000.0 in 2022, then soared by 38.26% to -$326000.0 in 2023, then slumped by 61.04% to -$525000.0 in 2024, then surged by 80.38% to -$103000.0 in 2025, then soared by 130.1% to $31000.0 in 2026.
- Business Quant data shows CVSI's Change in Cash at $31000.0 in Q1 2026, -$103000.0 in Q4 2025, and -$505000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | -103,000.00 |
| Sep 30, 2025 | -505,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | -525,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Jun 30, 2024 | -185,000.00 |
| Mar 31, 2024 | -655,000.00 |
| Dec 31, 2023 | -326,000.00 |
| Sep 30, 2023 | -47,000.00 |
| Jun 30, 2023 | 976,000.00 |
| Mar 31, 2023 | 103,000.00 |
| Dec 31, 2022 | -528,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | -1.33 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | -285,000.00 |
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | -2.71 Mn |